Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
NCT00924352Phase 2Completed
- Sponsor
- Accelerated Community Oncology Research Network
- Start
- Jun 2009
- Primary completion
- Oct 2013
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dasatinib, ixabepilone in breast cancer, sponsored by Accelerated Community Oncology Research Network. Started Jun 2009; status: completed.
02
Drugs
dasatinibixabepilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00924352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00924352.